ZIIHERA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $207,574 | 296 | 218 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $115,660 | 22 | 55.7% |
| Unspecified | $51,065 | 7 | 24.6% |
| Consulting Fee | $18,425 | 6 | 8.9% |
| Food and Beverage | $12,443 | 228 | 6.0% |
| Travel and Lodging | $9,981 | 33 | 4.8% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2) | JAZZ PHARMACEUTICALS INC. | $39,836 | 0 |
| PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform Trial | JAZZ PHARMACEUTICALS INC. | $11,230 | 0 |
Top Doctors Receiving Payments for ZIIHERA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | Durham, NC | $51,698 | 24 |
| Unknown | — | Houston, TX | $51,065 | 7 |
| , M.D | Student in an Organized Health Care Education/Training Program | Washington, DC | $13,824 | 10 |
| , MD | Hematology & Oncology | Williamsport, PA | $12,619 | 6 |
| , M.D | Hematology | Orlando, FL | $12,407 | 12 |
| Amit Mahipal | Hematology & Oncology | Rochester, MN | $11,822 | 7 |
| , M.D., PH.D | Medical Oncology | Orange, CA | $7,605 | 2 |
| , MD | Medical Oncology | Dallas, TX | $5,990 | 3 |
| , M.D | Internal Medicine | Peabody, MA | $4,447 | 5 |
| , MD | Hematology & Oncology | Avondale, AZ | $4,375 | 2 |
| , M. D | Medical Oncology | Cleveland, OH | $3,821 | 3 |
| , M.D | Hematology & Oncology | Shelbyville, TN | $3,683 | 4 |
| , MD | Medical Oncology | Charlotte, NC | $3,120 | 1 |
| , M.D | Medical Oncology | Westwood, KS | $2,800 | 1 |
| , MD | Hematology & Oncology | Chicago, IL | $2,516 | 1 |
| , FNP | Primary Care | Duarte, CA | $2,223 | 1 |
| , MD | Hematology & Oncology | Houston, TX | $1,400 | 1 |
| , NP | Nurse Practitioner | San Diego, CA | $967.50 | 1 |
| , PA-C | Physician Assistant | Fort Worth, TX | $936.00 | 1 |
| , MD | Internal Medicine | New York, NY | $191.83 | 1 |
| , M.D | Hematology & Oncology | Madison, WI | $191.83 | 1 |
| , MD | Internal Medicine | New York, NY | $191.83 | 1 |
| , MD | Medical Oncology | Seattle, WA | $191.83 | 1 |
| , M.D | Hematology & Oncology | Arlington, VA | $191.83 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $191.83 | 1 |
Manufacturing Companies
- JAZZ PHARMACEUTICALS INC. $207,574
Product Information
- Type Drug
- Total Payments $207,574
- Total Doctors 218
- Transactions 296
About ZIIHERA
ZIIHERA is a drug associated with $207,574 in payments to 218 healthcare providers, recorded across 296 transactions in the CMS Open Payments database. The primary manufacturer is JAZZ PHARMACEUTICALS INC..
Payment data is available from 2024 to 2024. In 2024, $207,574 was paid across 296 transactions to 218 doctors.
The most common payment nature for ZIIHERA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($115,660, 55.7% of total).
ZIIHERA is associated with 2 research studies, including "I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)" ($39,836).